Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 179

3.

Single and combined prothrombotic factors in patients with idiopathic venous thromboembolism: prevalence and risk assessment.

Salomon O, Steinberg DM, Zivelin A, Gitel S, Dardik R, Rosenberg N, Berliner S, Inbal A, Many A, Lubetsky A, Varon D, Martinowitz U, Seligsohn U.

Arterioscler Thromb Vasc Biol. 1999 Mar;19(3):511-8.

4.

Study of the prothrombin gene 20201 GA variant in FV:Q506 carriers in relationship to the presence or absence of juvenile venous thromboembolism.

Ehrenforth S, von Depka Prondsinski M, Aygören-Pürsün E, Nowak-Göttl U, Scharrer I, Ganser A.

Arterioscler Thromb Vasc Biol. 1999 Feb;19(2):276-80.

5.

The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation.

De Stefano V, Martinelli I, Mannucci PM, Paciaroni K, Chiusolo P, Casorelli I, Rossi E, Leone G.

N Engl J Med. 1999 Sep 9;341(11):801-6.

6.

The risk of recurrent venous thromboembolism among heterozygous carriers of the G20210A prothrombin gene mutation.

De Stefano V, Martinelli I, Mannucci PM, Paciaroni K, Rossi E, Chiusolo P, Casorelli I, Leone G.

Br J Haematol. 2001 Jun;113(3):630-5.

PMID:
11380448
7.

Prevalence of 20210 A allele of the prothrombin gene in venous thromboembolism patients.

Leroyer C, Mercier B, Oger E, Chenu E, Abgrall JF, Férec C, Mottier D.

Thromb Haemost. 1998 Jul;80(1):49-51.

PMID:
9684784
8.

Risk for subsequent venous thromboembolic complications in carriers of the prothrombin or the factor V gene mutation with a first episode of deep-vein thrombosis.

Simioni P, Prandoni P, Lensing AW, Manfrin D, Tormene D, Gavasso S, Girolami B, Sardella C, Prins M, Girolami A.

Blood. 2000 Nov 15;96(10):3329-33.

9.

Risk of recurrent venous thrombosis in homozygous carriers and double heterozygous carriers of factor V Leiden and prothrombin G20210A.

Lijfering WM, Middeldorp S, Veeger NJ, Hamulyák K, Prins MH, Büller HR, van der Meer J.

Circulation. 2010 Apr 20;121(15):1706-12. doi: 10.1161/CIRCULATIONAHA.109.906347. Epub 2010 Apr 5.

10.

Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives.

Aznar J, Vayá A, Estellés A, Mira Y, Seguí R, Villa P, Ferrando F, Falcó C, Corella D, España F.

Haematologica. 2000 Dec;85(12):1271-6.

11.

The VITA project: prothrombin G20210A mutation and venous thromboembolism in the general population.

Tosetto A, Missiaglia E, Frezzato M, Rodeghiero F.

Thromb Haemost. 1999 Nov;82(5):1395-8.

PMID:
10595625
12.

The risk of early recurrent venous thromboembolism after oral anticoagulant therapy in patients with the G20210A transition in the prothrombin gene.

Eichinger S, Minar E, Hirschl M, Bialonczyk C, Stain M, Mannhalter C, Stümpflen A, Schneider B, Lechner K, Kyrle PA.

Thromb Haemost. 1999 Jan;81(1):14-7.

PMID:
10348706
13.

Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism.

Emmerich J, Rosendaal FR, Cattaneo M, Margaglione M, De Stefano V, Cumming T, Arruda V, Hillarp A, Reny JL.

Thromb Haemost. 2001 Sep;86(3):809-16. Erratum in: Thromb Haemost 2001 Dec;86(6):1598.

PMID:
11583312
14.

Prothrombin A19911G polymorphism and the risk of venous thromboembolism.

Martinelli I, Battaglioli T, Tosetto A, Legnani C, Sottile L, Ghiotto R, Mannucci PM.

J Thromb Haemost. 2006 Dec;4(12):2582-6. Epub 2006 Sep 15.

PMID:
16981886
15.

The risk of venous thromboembolism in family members with mutations in the genes of factor V or prothrombin or both.

Martinelli I, Bucciarelli P, Margaglione M, De Stefano V, Castaman G, Mannucci PM.

Br J Haematol. 2000 Dec;111(4):1223-9.

PMID:
11167765
16.

Different circumstances of the first venous thromboembolism among younger or older heterozygous carriers of the G20210A polymorphism in the prothrombin gene.

De Stefano V, Rossi E, Paciaroni K, D'Orazio A, Cina G, Marchitelli E, Pepe R, Leone G.

Haematologica. 2003 Jan;88(1):61-6.

17.

The risk of recurrent venous thromboembolism in heterozygous carriers of factor V Leiden and a first spontaneous venous thromboembolism.

Eichinger S, Weltermann A, Mannhalter C, Minar E, Bialonczyk C, Hirschl M, Schönauer V, Lechner K, Kyrle PA.

Arch Intern Med. 2002 Nov 11;162(20):2357-60.

PMID:
12418950
18.

The risk of first venous thromboembolism during pregnancy and puerperium in double heterozygotes for factor V Leiden and prothrombin G20210A.

Martinelli I, Battaglioli T, De Stefano V, Tormene D, Valdrè L, Grandone E, Tosetto A, Mannucci PM; GIT (Gruppo Italiano Trombofilia).

J Thromb Haemost. 2008 Mar;6(3):494-8. doi: 10.1111/j.1538-7836.2007.02880.x. Epub 2007 Dec 19.

PMID:
18182035
19.

Risk of recurrent venous thromboembolism in patients with common thrombophilia: a systematic review.

Ho WK, Hankey GJ, Quinlan DJ, Eikelboom JW.

Arch Intern Med. 2006 Apr 10;166(7):729-36. Review.

PMID:
16606808
20.

Venous thromboembolic disease and the prothrombin, methylene tetrahydrofolate reductase and factor V genes.

Alhenc-Gelas M, Arnaud E, Nicaud V, Aubry ML, Fiessinger JN, Aiach M, Emmerich J.

Thromb Haemost. 1999 Apr;81(4):506-10.

PMID:
10235429
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk